Bristol-Myers Squibb investors have been dreading the arrival of Merck’s Keytruda in kidney cancer, one of Opdivo’s key growth areas. Bristol’s execs? Not so much. The company has been preparing for the launch of I-O-plus-TKI regimens—such as the marriage of Keytruda and Pfizer’s Inlyta that won FDA approval Monday, or the Bavencio-Inlyta duo that Pfizer… Read More »
Samyukta Mullangi By SAMYUKTA MULLANGI MD, MBA, DANIEL W. BERLAND MD, and SUSAN DORR GOOLD MD, MHSA, MA Jenny, a woman in her twenties with morbid obesity (not her real name), had already been through multiple visits with specialists, primary care physicians (PCPs), and the emergency department (ED) for unexplained abdominal pain. A plethora of… Read More »
Babies and toddlers should spend NO time looking at screens and under-fives be limited to one hour a day, World Health Organization tells parents Global health chiefs said too much screen time could lead to obese children The recommendations suggest doing puzzles, colouring or singing instead Past research showed more than half of UK children… Read More »
To address disparities between urban and rural hospitals, the Centers for Medicare and Medicaid Services is proposing to increase the wage index of low wage index hospitals, such as those in rural areas. WHY IT MATTERS The proposed rule would update Medicare payment policies for hospitals under the Inpatient Prospective Payment System and the Long-Term… Read More »